In fact, HCQ decreases the attachment of aPL-β2GPI complex to phospholipid bilayers and cells, protects the annexin V anticoagulant shield from disruption by aPL [108], and decreases thrombus size in murine models of APS [109]. Here, APOH is linked to autoimmune polyendocrinopathy.